SCHEMBL9761579

SCHEMBL9761579

CN(C)c1n[nH]c([N+](=O)[O-])c1CCCCN

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9761370 0.79 KDM4E (0.34) MEN1KMT2A
SCHEMBL9762371 0.76
SCHEMBL9762175 0.73 MAPT (0.33)
SCHEMBL9762532 0.72 ALDH1A1 (0.31)
SCHEMBL9761823 0.71
SCHEMBL9761640 0.69 HRH1 (0.33)
SCHEMBL9761268 0.69 CYP1A2 (0.37) MEN1KMT2A
SCHEMBL9762396 0.69 MAPT (0.33)
SCHEMBL9761142 0.68 NPC1 (0.46) MEN1KMT2A
SCHEMBL9762325 0.67 ALDH1A1 (0.33) MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5026694-A Antitumor agents THE BRITISH COLUMBIA CANCER FOUNDATION (CA) 1991-06-25 US disclosed